KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Liabilities and Shareholders Equity (2018 - 2025)

Adaptive Biotechnologies' Liabilities and Shareholders Equity history spans 8 years, with the latest figure at $512.7 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 4.94% year-over-year to $512.7 million; the TTM value through Dec 2025 reached $2.0 billion, down 12.69%, while the annual FY2025 figure was $512.7 million, 4.94% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $512.7 million at Adaptive Biotechnologies, up from $490.6 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $1.1 billion in Q1 2021 and bottomed at $490.6 million in Q3 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $741.1 million (2023), against an average of $733.8 million.
  • The largest annual shift saw Liabilities and Shareholders Equity grew 22.54% in 2021 before it decreased 23.5% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $923.3 million in 2021, then fell by 7.23% to $856.6 million in 2022, then fell by 22.82% to $661.1 million in 2023, then dropped by 18.42% to $539.4 million in 2024, then decreased by 4.94% to $512.7 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Liabilities and Shareholders Equity are $512.7 million (Q4 2025), $490.6 million (Q3 2025), and $496.6 million (Q2 2025).